Adapting the STRW Intervention for Adolescents and Young Adults With Epilepsy (ARGOS)

Running, not enrolling · Not applicable

Conditions studied: Epilepsy, Epilepsy in Youth, Activities, Daily Living

In brief

The goal of this clinical trial is to learn if a telehealth intervention (Surviving and Thriving in the Real World; STRW) is helpful to improve daily living skills for teens and young adults with epilepsy. It will also learn about the acceptability, feasibility, and satisfaction of the intervention. The main questions it aims to answer are: * Is STRW an acceptable, feasible, and satisfactory intervention for teens/young adults and their caregivers? * Does STRW improve daily living skills (e.g., cooking, laundry, money management) for teens and young adults with epilepsy? This is a nonrandomized pilot trial and all participants who enroll will: * Participate in weekly caregiver/teen dyads ( approximately 60 minutes) focused on improving daily living skills with a trained therapist for 15 weeks. * Participate in weekly caregiver groups (approximately 90 minutes) focused on supporting caregivers in coaching their teens in daily living skills development led by 2 trained therapists for 14 of the 15 intervention weeks. * Complete measures of adaptive functioning (to evaluate daily living skills; parent and teen-report) at the start of the study and post-intervention. Additional measures will also be collected. * Have the option to complete post-intervention interviews to provide feedback on the intervention components.

Key facts

Study ID

NCT07676539

Run by

Children's Hospital Medical Center, Cincinnati

People needed

8

Starts

2025-12-03

Expected to finish

2026-07-01

Last updated by the study team

2026-07-08

Who can join

Age: 14 and older, up to 19. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosed with epilepsy at least 1 year ago,
• enrolled in 9th-12th grade (i.e., 14-18 years old at time of enrollment)
• deficits in adaptive functioning per caregiver report (i.e., standard score below 90 on either the ABAS-3 Practical Domain or General Adaptive Composite [GAC]),
• not planning to wean off anti-seizure medication (ASM) within the intervention timeframe,
• and family's primary language is English.

You may not qualify if…

• Parent- or clinician-reported history in the adolescent/young adult of:
• history of developmental delay (e.g., autism spectrum disorder, pervasive development disorder, history of services for developmental delay or intellectual impairment in the past 5 years, known IQ<70),
• severe mental illness (e.g., schizophrenia, bipolar disorder, eating disorder within the past 12 months),
• currently on the ketogenic diet,
• and history of epilepsy surgery in the past year.
• Clinician-reported diagnosis in the adolescent/young adult of:
• one or more episodes of status epilepticus within the 24 weeks prior to enrollment
• treatable causes of seizures (for example, identified etiologies including metabolic, neoplastic or active infectious origin),
• a confirmed or suspected epileptic encephalopathy (e.g., electrical status epilepticus in sleep, Landau Kleffner syndrome, West syndrome),
• a confirmed or suspected progressive and degenerative disorder (e.g., mitochondrial disorders, metabolic disorders, autoimmune disorders),
• non-epileptic events/seizures.

Where it is running

• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.